Geode Capital Management LLC Has $304.22 Million Stock Position in Nutrien Ltd. $NTR

Geode Capital Management LLC lifted its position in shares of Nutrien Ltd. (NYSE:NTR) by 6.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,833,284 shares of the company’s stock after buying an additional 309,025 shares during the quarter. Geode Capital Management LLC’s holdings in Nutrien were worth $304,217,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of NTR. Arrowstreet Capital Limited Partnership lifted its position in shares of Nutrien by 19.1% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 14,221,381 shares of the company’s stock valued at $834,962,000 after acquiring an additional 2,276,651 shares during the period. TD Asset Management Inc raised its stake in Nutrien by 16.5% in the third quarter. TD Asset Management Inc now owns 7,368,861 shares of the company’s stock valued at $432,838,000 after purchasing an additional 1,043,766 shares in the last quarter. Black Creek Investment Management Inc. raised its stake in Nutrien by 57.3% in the third quarter. Black Creek Investment Management Inc. now owns 2,367,244 shares of the company’s stock valued at $139,050,000 after purchasing an additional 862,487 shares in the last quarter. Allianz Asset Management GmbH raised its stake in Nutrien by 152.6% in the third quarter. Allianz Asset Management GmbH now owns 1,372,863 shares of the company’s stock valued at $80,662,000 after purchasing an additional 829,275 shares in the last quarter. Finally, Man Group plc raised its stake in Nutrien by 5,178.4% in the third quarter. Man Group plc now owns 775,919 shares of the company’s stock valued at $45,577,000 after purchasing an additional 761,219 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Nutrien Stock Up 1.4%

Shares of NYSE NTR opened at $69.53 on Tuesday. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35. The company has a market cap of $33.37 billion, a price-to-earnings ratio of 14.16, a PEG ratio of 0.63 and a beta of 0.60. Nutrien Ltd. has a 12 month low of $53.03 and a 12 month high of $85.36. The stock has a 50-day moving average price of $72.77 and a two-hundred day moving average price of $68.63.

Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.48 by $0.03. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business’s quarterly revenue was up 18.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.11 earnings per share. As a group, analysts forecast that Nutrien Ltd. will post 5.45 earnings per share for the current fiscal year.

Nutrien Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.20 annualized dividend and a yield of 3.2%. Nutrien’s payout ratio is presently 44.81%.

Wall Street Analyst Weigh In

A number of research firms recently commented on NTR. Scotiabank boosted their price target on Nutrien from $75.00 to $80.00 and gave the company a “sector perform” rating in a research note on Monday, May 11th. Raymond James Financial raised Nutrien from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $74.00 to $90.00 in a research note on Tuesday, May 5th. Royal Bank Of Canada boosted their price target on Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research note on Tuesday, April 7th. Zacks Research downgraded Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 2nd. Finally, Morgan Stanley boosted their price target on Nutrien from $77.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, April 8th. Eleven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $82.75.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.